Atlas Trials

Thomas Aagaard Rasmussen

1 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Thomas Aagaard Rasmussen

RecordFirmDate
Inhibiting the Anti-apoptotic Factor, BCL-2, at the Time of ART Initiation to Promote Apoptosis of HIV-infected Cells and Restrict the Seeding of the HIV Reservoir (The INITIATE Study) (NCT07481175)Thomas Aagaard Rasmussen2026-04-13

Track Thomas Aagaard Rasmussen automatically

Every clearance here is in the API, with alerts when new ones post.